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Abstract
Background: Brief messaging interventions, including Short Message Service (SMS) text-messages, delivered via
mobile device platforms, show promise to support and improve treatment adherence. To understand how
these interventions work, and to facilitate transparency, we need clear descriptions of the intervention
development process.
Method: We describe and reflect on the process of designing and pretesting an evidence- and theory-informed brief
messaging intervention, to improve diabetes treatment adherence in sub-Saharan Africa. We followed the stepwise
approach recommended by the Medical Research Council, United Kingdom (MRC UK) Framework for Development
and Evaluation of Complex Health Interventions and guidance for mobile health intervention development.
Results: We used a four-phase, iterative approach that first generated primary and secondary evidence on the lived
experience of diabetes, diabetes treatment services and mobile-phone use. Second, we designed a type 2 diabetes-
specific, brief text-message library, building on our previous hypertension text-message library, as well as drawing on
the primary and secondary data from phase one, and on expert opinion. We then mapped the brief text-messages
onto behaviour change (COM-B) theoretical constructs. Third, we refined and finalised the newly developed brief text-
message library through stakeholder consultation and translated it into three local languages. Finally, we piloted the
intervention by pre-testing the automated delivery of the brief text-messages in the trial sites in Malawi and South
Africa. The final SMS text Adherence suppoRt for people with type 2 diabetes (StAR2D) intervention was tested in a
randomised controlled trial in Malawi and South Africa (trial registration: ISRCTN70768808).
Conclusion: The complexity of public health interventions requires that we give more attention to intervention
development work. Our documentation and reflection on the StAR2D intervention development process promotes
transparency, replicability, assessment of intervention quality, and comparison with other studies.
Keywords: Mobile health (mHealth), Formative intervention development, Brief SMS text-messaging, Behaviour change
theory, Treatment adherence, Type 2 diabetes, Qualitative research, Sub-Saharan Africa
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Contribution to the literature
 To optimise the success and uptake of mobile health
(mHealth) interventions, researchers are starting to
identify the evidence and theoretical basis for
developing mHealth interventions.
 We build on this work by describing and
reflecting on the process of designing and
pretesting an evidence- and theory-informed brief
messaging intervention to improve diabetes treatment
adherence in sub-Saharan Africa. This promotes
transparency, replicability, assessment of intervention
quality, and comparison with other studies.
 We showed that despite differences in the two
sub-Saharan African settings, patients’ experiences
and health care journeys were similar, which
bodes well for future development of standard
diabetes messaging across different contexts.
Background
Type 2 diabetes is major global public health concern
[1]. Low- and middle-income countries (LMICs) are dis-
proportionally affected by the substantial and growing
burden of premature morbidity and mortality associated
with chronically elevated blood glucose levels [2, 3].
Health outcomes for people treated for type 2 diabetes
could be substantially improved in sub-Saharan Africa,
but failure to take medicine regularly to treat diabetes
(described as non-adherence) has been identified as a
major problem [1]. Reasons for not collecting or taking
medications as intended are well documented and
include psychological factors, lack of social support, low
levels of health literacy, and interactions with the health
care system that do not support self-management [1, 4–7].
Mobile health (mHealth) interventions delivered by brief,
Short Message Service (SMS) text-message (referred to here
as brief messaging) for targeted client communication has
been recommended for health issues regarding sexual,
reproductive, maternal, and newborn health [8] and for ad-
herence to anti-retroviral treatment and smoking cessation
initiatives [9]. Brief text messaging is showing promise for
supporting adherence and health behaviour in a range of
conditions [9, 10], including for diabetes [11–14]. However,
impact is inconsistent across studies [9, 11, 12, 14, 15],
prompting researchers to call for more robust, large-scale
research on better ways to develop and test digital commu-
nication technology for treatment adherence for diabetes
and other chronic disease [5, 9, 11, 12, 14, 16, 17]. This
should include evidence- and theory-informed formative
work on mHealth intervention design and development to
enhance the credibility, quality, and relevance of mobile
health interventions for diabetes support [5, 11, 12, 18].
An investigation to understand the drivers of interven-
tion development processes concluded that intervention
designers often find it challenging that intervention design
does not necessarily proceed in a predictable and
controlled manner from acquired knowledge, and that
there is a need for more guidance [19, 20]. Many mHealth
interventions aimed at promoting healthy behaviour do
not show what evidence or theory underpinned the
message content or timing [11, 12, 21], whether and how
a user-centred design approach was used [22], or whether
there was any pretesting of the intervention [23]; though
this is changing [24]. Accessible and transparent docu-
mentation of brief message interventions can help unpack
the ‘black-box’ of intervention development to allow for
appraisal of the quality and credibility of the intervention,
show how it is adapted for local context, allow replicability
and comparability with other studies, and improve our un-
derstanding of how and why the intervention might work
[25]. There is a growing body of literature showing how
researchers are identifying the evidence and theoretical
basis for developing interventions [16, 24–36], including
for mHealth interventions for diabetes [37, 38]. We are
building on this work by describing and reflecting on the
process of designing and pretesting an evidence- and
theory-informed brief messaging intervention to improve
diabetes treatment adherence in sub-Saharan Africa.
Methods
Study approach
We report here on the year-long formative work to
develop and refine the StAR2D intervention prior to
experimental testing. Following the period of formative
work, the SMS text Adherence suppoRt for people with
type 2 diabetes (StAR2D) intervention was tested in a
pragmatic randomised controlled trial (RCT) in Malawi
and South Africa in 2018 (trial registration: ISRC
TN70768808). The aim of the RCT was to test the
effectiveness of sending brief, automated SMS text-
messages for improving health outcomes and medication
adherence in patients with type 2 diabetes, compared to
an active control, as detailed in the published protocol
[39]. The primary focus is on adherence to medical
treatment (attending appointments, collecting medicine,
taking medicine) with secondary focus on adjunct
general health and wellbeing strategies (i.e., food and
eating, physical activity, tobacco and alcohol, stress
management).
Intervention design necessitates a coherent idea of the
evidence and theory behind the proposed intervention,
adaptation to local context, and pilot testing before
proceeding to an experimental or quasi-experimental
study [24, 25, 40, 41]. In this paper, we report only on
the formative work to develop the STAR2D intervention.
The aim of the StAR2D intervention development study
was to ensure the final brief (SMS) text-message inter-
vention was theory- and evidence-informed, relevant,
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and acceptable to the target audiences, and appropriately
aligned with the organisation of clinic care at the trial
sites. Intervention messages were meant to advise people
about the benefits of their diabetes treatment and offer
motivation and encouragement around lifestyle and use
of medication. We followed a step-wise approach as
recommended by the Medical Research Council, United
Kingdom (MRC UK) Framework for Development and
Evaluation of Complex Health Interventions [40, 41] and
other studies that provided guidance on the steps for
intervention development of evidence- and theory-
informed mHealth interventions for behaviour change
[21, 22, 25, 42]. The primary focus of this paper is to
document a systematic, transparent approach to inter-
vention development in the context of an intervention
that was tested experimentally. A secondary, but import-
ant focus is on the evidence generated in each phase to
illustrate its contribution to shaping the final intervention.
Study setting
We identified two trial sites, one in Lilongwe, Malawi,
and one in Cape Town, South Africa, both in urban/
peri-urban sites with a high burden of type 2 diabetes,
with free public sector health facilities, serving popula-
tions living in low socio-economic settlements.
Data collection and analysis
For the intervention development study, data collection
took place at these two trial sites, and in the initial stage,
in a third, site in Johannesburg, South Africa. We con-
ducted primary research to seek input from adult health
care users with type 2 diabetes, as well as health care
providers involved with diabetes health care (including
primary care nurses, doctors, pharmacists, administrative
support staff and health facility management). Secondary
data sources were identified through literature searches
and included document review of local diabetes policy
and clinical guidelines. We did not conduct a full
systematic literature review. Our pragmatic approach
was a combination of identifying relevant systematic
reviews to start with, hand-searching of relevant papers
in systematic reviews, and a general targeted literature
search for key articles.
We followed four phases of intervention development
(as shown in Fig. 1). For each of the four phases, we
describe the aim and methodological approach, provide a
summary of the results that emerged from that phase, and
reflect on how this contributed to shaping the content of
the intervention. For this description and reflection, we
draw on the primary and secondary data collected in the
four phases, as well as on our operational research docu-
mentation (protocols, operational plans, project manage-
ment meeting notes and discussions).
We used multiple, qualitative research strategies over a
12-month period of intervention development (2016–17).
In the Results section, we provide an overview of the
methods for each phase, as this is part of our intervention
description. For ease of reading, we provide an overall
summary of the data sources for the formative work.
Phase 1:
 We drew on evidence from the secondary data
sources (literature and document reviews) and
primary research.
 We conducted patient focus group discussions
(FGDs) with adults with type 2 diabetes (12 FGDs,
89 participants in total, 58% female):
 Lilongwe, Malawi: three single gender FGDs, two
with males (14 participants, age range 28–78 years)
and one with females (7 participants, age range
19–63 years)
 Cape Town, South Africa: six mixed gendered and 1
one female FGDs (8 male and 32 female
participants, age range 47–80 years) *
 Johannesburg, South Africa: one male FGD (15
participants, age 21–70 years) and one female FGD
(13 participants, age 42–68 years)
 Field observation was done to map the organisation
of health services and patient care pathways for
diabetes treatment in both trial sites.
Phase 2:
Our data sources for this phase were:
 SMS library from the previous hypertension
adherence study
 Data collected in Phase 1 (primary, secondary and
mapping exercise)
 COM-B behaviour change taxonomy: We used
theory-informed behaviour change constructs to
guide the content of the messages as proposed by
the Capability, Opportunity, Motivation-Behaviour
(COM-B) theory [43–45]. The COM-B framework
is widely used for studying behaviour change in
adherence, has the benefit of consolidating evidence
from a range of other behaviour theories, and can
account for contextual factors (like socio-economic
conditions and health service factors) [43, 45–47].
Phase 3:
We conducted FGDs with adults with type 2 diabetes
(6 FGDs, 56 participants in total, 59% female):
 Lilongwe, Malawi: two male FGDs (16
participants, age range 29–68 years), and two
female FGDs (16 participants, age range 38–72
years). Time since their diabetes diagnosis ranged
from 1month to 16 years.
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 Cape Town, South Africa: two mixed gender FGDs
(7 male and 17 female participants, age range 38–71
years). We ensured a mix of people from the two
main language groups in the catchment area
(isiXhosa and Afrikaans). *
 We conducted in-depth qualitative interviews (IDIs)
with 11 patients and 18 health care facility staff in
the trial sites.
 We conducted five consultations with experts
external to the trial team, including in diabetes
health promotion (3), nutrition (1), and exercise (1),
and we asked the clinical experts in trial team to
review the message content, language, and tone.
Phase 4:
 For the pilot testing, we conducted brief (less than 5
min) weekly telephone interviews with 10 patients in
each site over a 3-week period to check the technical
delivery of the intervention and how messages were
understood.
* (There are gaps in data on age and time since diag-
nosis as this information was not consistently collected).
We chose to use both in-depth interviews and focus
group discussions as combining these methods can
facilitate a deeper comparison of perspectives, improve
data completeness, and enhance the trustworthiness of
findings [48]. While interviews enable one to explore
individual views and experiences in detail, the conversa-
tional nature and interaction in a focus group can help
generate additional insights, test and refine understand-
ings gained in individual interviews, and stimulate com-
mentary that may not have been elicited from individual
interviews [49]. See Additional file 1 for the interview
guide used for individual interviews and focus groups
conducted in phase 1.
In Phase 1 and 3, patient participants were selected
through a combination of purposive and convenience
sampling. In purposive sampling, we aimed to recruit a
diverse group of participants that resemble the diabetes
patient population in terms of gender, age, and duration
of diabetes. Convenience sampling was done with the
help of nurses alerting patients to the study and recruit-
ment of participants in waiting rooms. For the pilot test-
ing in phase 4, we recruited from participants from
phase 3. Staff participants were purposively selected and
included staff and management associated with delivery
of the diabetes service, including facility management,
clinical staff, and health promoters. Two health experts
(nutrition and exercise) and two health promotion
experts (one in Malawi and one in Cape Town) partici-
pated. They were recruited based on recommendations
from other health providers and people in the trial
research team.
Data analysis for the primary data collected in phase 1
was analysed using a thematic analysis approach. Focus
group and individual interviews were audio recorded,
transcribed, and coded by one researcher (NLn) using a
set of codes we developed based on the research ques-
tion, interview schedule, and initial themes emerging
from the early interviews. As a first step in the analysis,
the researchers compiled an interview summary within
36 h of conducting the interviews and focus groups to
summarise the main content and provide researcher
reflections. These were used for initial analysis in the it-
erative data analysis process. Analysis of data collected
in phase 3 and 4 focussed on identifying key issues and
recommendations to consider in refining the draft
diabetes text message library. Standard approaches to
ensuring the quality of the methodology were used,
including the use of a coding framework and review of
the final themes by researchers who conducted the data
collection.
For this description and reflective analysis, we draw on
the data described above. We also draw on our project
documentation (operational plans, meeting minutes, in-
terim reports), and reflect on our formative work, almost
as if we are participant observers of our own processes.
In the Results section, we provide an overview of the
methods per phase (in Figs. 2, 3, and 4), and in the
narrative, we highlight key findings and reflect on issues
that shaped the intervention development. Findings from
elements of the primary qualitative data have been
published elsewhere [50].
Ethical approval
The protocol was approved by the University of Oxford
Tropical Research Ethics Committee (OXTREC, ref.:
22-15), the University of Cape Town Research Ethics
Committee (UCT HREC, REF: 126/2015), the University
of Witwatersrand Research Ethics Committee (R14/49)
and the Malawi National Health Services Research
Committee (NHSRC #15/7/1425). In addition, the
relevant health authorities granted permission for the
study, including the intervention development work.
All participants who were included in the formative
study provided written, informed consent to participate.
Results
The intervention development process: designing, refining,
pre-testing and piloting of the StAR2D intervention
We employed a stepwise and iterative process for the inter-
vention development (or formative) study, as illustrated in
Fig. 1. To summarise: first, we identified diabetes patients’
experiences and perceptions of diabetes and treatment,
and then we used this evidence to build on a previous set
of text-messages we had designed for a trial on blood pres-
sure control [26, 51]. Through a process of consultation
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with stakeholders (patients, staff, StAR2D trial research
team members, health promotion experts), and using the
primary and secondary evidence we collected, we designed
a draft brief text-message library with 222 content mes-
sages. Through further consultation with stakeholders,
we finalised a library of 156 brief text-messages (and 16
trial-related messages) and translated it into three local
languages.
We used theory-informed behaviour change constructs
to guide the content of the messages, as proposed by the
Capability, Opportunity, Motivation-Behaviour (COM-
B) theory [43–46]. The COM-B theory states that an
individual needs adequate capability, opportunity, and
motivation for a behaviour to take place (such as taking
medicine), and that a deficit in any of these three areas
means the behaviour is unlikely to occur. An individual’s
capability to adhere may be affected by psychological
factors of knowledge and memory, opportunity may be
affected by physical and social barriers to access
medicine and support, and motivation may be affected
by psychological factors such a self-confidence, values
and beliefs [52].
Finally, we pilot-tested the automated, brief (SMS) text
delivery system with the intended target audience before
handing over the final StAR2D brief text-message library
to be tested in the StAR2D RCT study. Below, we pro-
vide a detailed description of, and reflection on, each of
the four phases shown in Fig. 1. In Additional File 2, we
provide a TIDier checklist with a summary description
of the final StAR2D intervention that was experimentally
tested [39].
Phase 1: evidence on experiences and perceptions of
diabetes, diabetes treatment and mobile phone use
To inform the content of the SMS brief text-messages
and other delivery components (timing, frequency,
language preferences), we gathered information from
secondary sources (systematic and literature reviews and
Fig. 1 The four phases of the StAR2D intervention development process
Fig. 2 Phase 1: aims, methods and outcomes
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clinical guidelines) for pertinent information on patient’s
experience of diabetes and adherence. We conducted
primary research on experiences and perceptions of dia-
betes, diabetes care, and treatment services with patients
and staff. We explored patient access, use of mobile
phones, and attitudes to mobile phone messaging.
Through field observation and staff interviews in local
clinics, we mapped the provision of diabetes care
services at the two trial sites to allow the tailoring of
messages to the local service delivery context. As shown
in Fig. 2, we summarise the aims, methods, and outcomes
of the first phase of the intervention development study.
Generating evidence on experiences of diabetes,
treatment and mobile phone use In Malawi, patient
participants were a mix of urban and rural, which con-
trasted with predominantly urban participants in South
Africa. Nevertheless, patient participants across the coun-
try settings identified similar experiences, struggles, and
needs. Many experienced their diabetes diagnosis with
shock and disbelief at first. Participants felt supported by
family and their faith, which helped them come to terms
with and cope better with the illness. Generally, partici-
pants understood and accepted the need for long-term
medical treatment, but they had lingering questions about
the underlying reasons for their disease, and uncertainties
about how best to manage their illness.
For the most part, participants described themselves as
adherent in terms of picking up their medicine as required
and taking the medicine as prescribed. Some acknowl-
edged that adherence was an ongoing struggle for them.
Several patients took pride in themselves for being ‘good’
patients when it came to taking their medicine as pre-
scribed. However, when probing, there was a wide
spectrum of understanding and practice of what consti-
tuted “good” adherence. Both sets of participants (those
who reported being adherent and less than adherent)
identified a range of personal, social, economic, health sys-
tem struggles, including family and socio-economic
stressors. Situations that posed a risk (for disrupting nor-
mal patterns of eating and taking of medication) were sub-
stance misuse, social engagements (family or other social
gatherings and festivities) and travelling. Experiences with
the health services also posed a risk to adherence. Issues
included medicine stock-outs, long waiting times and dif-
ficult patient-staff interactions.
For the most part, men and women had similar experi-
ences of living with diabetes. One gendered difference we
observed was the dependence of some men on their fe-
male partners. These men noted that their female partners
were their main source of social and emotional support in
coping with diabetes (including helping them to eat more
healthily). Another related, but more stark gendered dif-
ference was that several men (women also, but more so in
men) expressed concerns about the effect of diabetes on
their sexual health and well-being. The men feared that
sexual dysfunction could jeopardise their intimate partner-
ships and also threaten their main source of social sup-
port. Details of this gendered concern about sexual well-
being are described elsewhere [50]. We refrained from in-
cluding messaging on sexual function and diabetes as we
thought the topic was too complex to address through the
medium of a text message.
Participants reported ongoing struggles with accessing
appropriate health information. It was especially hard for
them to find practical information about healthy living that
fit with their lives and poor socio-economic conditions.
They asked for text-messages to include practical, locally
relevant advice on healthy eating and keeping active.
Where feasible, these issues were addressed in the text
messaging in various ways, as discussed in Phase 2 below.
We examined mobile phone access and use to explore
the feasibility and acceptability of sending patients brief
text messaging in support of medication use for diabetes.
Participants had access to either their own or a shared
phone (a mixture of basic and smart phones) and could
operate these devices by themselves (or with the help of
family) to receive and send messages, and everyone used
some form of SMS text messaging. For those with smart
phones, the cost of internet access was often prohibitive.
They were comfortable with the idea of receiving health
promotion-related messaging on their phone but wanted
a way to easily distinguish health messaging from spam
messages. In particular, they asked that the message
sender be identified as coming from the health services
to avoid it being deleted as spam. They wanted the
option of receiving messages in their first language.
The patient flow and treatment pathways were studied
by observing how the diabetes services were delivered at
each trial site. This provided us with locally relevant data
that could be used to tailor the messages for each site
regarding frequency of medication pickup and medical
appointment, as well as the expected patient flow and
treatment pathways from entering to exiting the facility.
Phase 2: drafting the evidence and theory-informed brief
text-message library
In Phase 2, we designed a draft set of brief text-messages
suitable for supporting adherence to diabetes care. This
involved three steps. The first was adapting a previous set
of text-messages on hypertension adherence. This set was
also developed with patient and provider input [26]. The
second step was to craft new diabetes-specific messages
drawing on the primary and secondary evidence on dia-
betes and mobile phone experience that we generated in
Phase 1. Thirdly, we mapped the messages onto known
behaviour change strategies. Table 1 shows the structure,
topics, and examples of the final brief text-message library.
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It consists of 156 diabetes content-related messages and
16 trial-related message. The main components are en-
hancing primary adherence (medical treatment) and en-
hancing secondary adherence (general health and well-
being). We decided a-priori on the ratio of messages, with
most of the messages focussing on supporting medication
use, in line with the primary focus of the trial.
Message content development Many health risk behav-
iours for high blood pressure (HBP) and type 2 diabetes
are shared, so messages in the blood pressure study that
were broadly applicable to both were reviewed and
retained. Many people with type 2 diabetes also have
comorbid HPB, so messages that would be helpful for this,
and for general adherence, were also retained.
Drawing on the literature, clinical guidelines, and in-
put from participants (patients, staff and health promo-
tion experts), we designed additional brief messages. In
phase 1, participants identified a range of challenges to
being adherent and raised the need for information,
encouragement, and practical advice. Where feasible, the
message content we developed addressed these
informational and support needs, including acknowledg-
ing stressors and providing encouragement, affirming
patient efforts, and encouraging self-efficacy. Besides the
need for reminders to pick up and take medicine, mes-
sages aimed to increase awareness of the long-term na-
ture of the disease, the need to prevent complications,
and the importance of healthy living.
Participants specifically asked for information and
advice to help them have a healthier lifestyle. They
wanted to know what ingredients they could substi-
tute for the regular food items they consumed (those
food items they considered unhealthy) and how to
measure the right portions/quantities for meals. With
the help of a nutritionist with expertise in behaviour
change, and drawing on local health promotion mate-
rials, we designed messages about healthy nutritional
options, considering the local context. Messages gave
advice, amongst others, on how to cut down on po-
tentially unhealthy snacks (such as sweets and sugary
drinks), substituting healthier alternatives for flavour-
ings like salt, finding healthier local alternative foods,
healthier food preparation, eating a balanced diet, and
Table 1 StAR2 brief text-message library: structure and examples
A: ENHANCE MEDICAL ADHERENCE Number of SMSs
1. Medication collection
Example: “We think it might be nearly time for your next medicine date. Please check your clinic card and
come on your date. Thnx [DiabetesTeam@Van Clinic]”
22
2. Medical appointment
Example: “Attending clinic appointments will help you stay healthy. Pls plan ahead for your arrangements
(travel, work, childcare). Thnx [DiabetesTeam@Van Clinic]”
19
3. Taking medication regularly
Example: “Taking your diabetes and other meds as prescribed means that you are in control of your
health. Keep it up! Thnx [DiabetesTeam@Van Clinic]”
48
4. Medical adherence support: general
Example: “It’s easy to forget to take your meds at social occasions. Keeping some meds in your wallet or
pocket could help. Thnx [DiabetesTeam@Van Clinic]”
18
Subtotal 107
B: ENHANCE GENERAL HEALTH AND WELL-BEING
1. General health and well-being
Example: “Taking your meds, exercising and eating healthy can improve your blood sugar levels and
prevent or reduce complications. Thnx [DiabetesTeam@VanCHC]”
27
2. Exercise, nutrition, and health
Example: “Being more active can help you feel more energetic. Walking, standing, jumping are healthier
than sitting. Thnx [DiabetesTeam@Van Clinic]”;
“Healthier eating includes eating a variety of protein (beans, meat, fish and eggs), more vegetables and less
starchy foods. Thnx [DiabetesTeam@VanCHC]”
9
3. Smoking and drinking
Example: “Smoking increases your risk of hypertension, heart disease & stroke, so it’s better to avoid smoking
or cut down. Thnx [DiabetesTeam@Van Clinic]”
6
4. Stress management
Example: “Coping with diabetes and a busy life can be stressful. Learning to manage your stress better can




C: TRIAL-RELATED AND GENERAL 16
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limiting portion sizes. We included messages on ways
to limit the high-risk situations participants had iden-
tified (such as social events and travelling). Message
content aimed not only to provide active reminders
and practical information, but also to instil a sense of
hope and self-responsibility. Several messages focussed
on encouragement, motivation, and providing oppor-
tunity for initiating positive behaviour change. These
included messages that acknowledged their life
stressors as well as their frustrations with the health
services, and messages encouraged them to view the
health service as a partner in managing their disease.
We categorised the final set of 156 messages into 90
‘core’ messages. These were messages that had unique
content and expressed a key idea or behaviour change
mechanism (e.g. shaping knowledge, cue to social sup-
port, practical reminders or lifestyle advice). The rest
were variations on those core messages. We had a suffi-
cient quantity and variation of messages to send regular
appointment and prescription pick-up reminders (these
were standard and repeated), as well as additional mes-
sages using a frequency not more than 4 times per week,
sent on random days. Participants had the option of not
receiving a message on at least one day of the week to
suit their preference. For instance, some participants did
not want to receive messages on days that they practiced
religious observances, and messages could be tailored to
such individual patient preferences.
Mapping messages to represent behaviour change
techniques To increase the chance of the messages
having the desired positive effect on adherence behav-
iour, we wanted the messages to reflect directly, or
indirectly, a known behaviour change strategy [29, 30,
45–47]. This would also later assist our process evalu-
ation after the trial, where we intended to examine
the potential causal pathways that may explain patient
behaviour change (or lack thereof). Table 2 shows ex-
amples of how each message was mapped onto a be-
haviour change technique.
We examined each message for its underlying
intention (by asking what kind of change the message
intended to produce, and through what mechanism),
and then categorised messages under the three key
components of the COM-B behaviour change theory
constructs which focusses on capability, opportunity,
and motivation factors for changing behaviour [43, 44].
We refined this by allocating messages to one of the 16
most common clusters of behaviour change techniques
identified by Michie et al. [43]. The mapping was done
in stages, first by one researcher (KB) who mapped the
whole library. This was reviewed by the lead researcher
(NLn) and another (SC), sitting together. We balanced
the number of messages in each of the key behaviour
change domains (Capability, Opportunity, Motivation)
and resolved disagreements by consensus among the 3
researchers.
Table 2 Examples of text-messages mapped onto COM-B behaviour change techniques
Brief text message COM-B behaviour change domain and techniques
Struggling to remember to pick up your meds? A trusted friend or family member could help
remind you. Thnx [DiabetesTeam@VanClinic]
CAPABILITY
Social Support – cue to action
Your good health is important. Pls take your meds as prescribed for all your health problems,
even if you feel fine. Thnx [DiabetesTeam@VanClinic]
MOTIVATION
Addressing known triggers for sub-optimal adherence
Attending clinic appointments will help you stay healthy. Pls try to plan ahead for your
arrangements (e.g. travel, work, child care). Thnx [DiabetesTeam@VanClinic]
OPPORTUNITY
Enhancing physical opportunity (mobilise time and
resources)
It’s easy to forget your meds at home when travelling. Pls remember to take your meds along
on your trip. Thnx [DiabetesTeam@VanClinic]
CAPABILITY
Building flexible knowledge of strategies to have
medicines available to take
Well-controlled blood sugar (taking your meds & a healthy lifestyle) helps decrease the risk of a
stroke. Thnx [DiabetesTeam@VanClinic]
CAPABILITY
Psychological capability - knowledge of natural disease
progression
Caring for your feet is really important. Ask us for information on how to look after your feet.
Thnx [DiabetesTeam@VanClinic]
CAPABILITY
Enhancing psychological capability for self-management
Sugar diabetes can affect anyone. Men, women & people of all ages, in all countries are living
with sugar diabetes. Thnx [DiabetesTeam@VanClinic]
OPPORTUNITY
Social opportunity - encouraging social norms that
disease is not due to personal failing
It can be difficult to change what you eat. Try to make a few small changes to your diet that
you can stick to. Thnx [DiabetesTeam@VanClinic]
OPPORTUNITY
Social opportunity -cue to action
Healthy food is not always expensive. Beans and eggs provide good protein and cost less than
meat. Thnx []DiabetesTeam@VanClinic]
MOTIVATION
Reflection, evaluation and challenging automatic
processes
Losing weight can be hard. Start with small steps, like eating a fruit for a snack instead of
biscuits or sweets. Thnx [Dr@VanClinic]
OPPORTUNITY
Social opportunity - cue to action
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Phase 3: refine, pre-test and translate brief text-messages
Message pre-testing As outlined in Fig. 3, we tested
and further refined the brief text-messages through pri-
mary research with stakeholders and expert consultation.
We purposively selected a sample of 15 messages for in-
depth testing in patient focus groups and staff interviews.
The selection criteria were informed by our need to
investigate issues of language and tone, understandability,
compatibility, acceptability, relevance, and usefulness. We
asked participants to review the appropriateness of the
translated versions of the 15 messages. We explored and
refined our assumptions about the underlying behaviour
change mechanisms of these messages, using cognitive
interviewing techniques (often used in market research)
[53] by asking participants what they understood by each
message, and what reactions the messages elicited (in
terms thoughts, feelings, and potential behaviour and
action). Below, we highlight a few key issues we addressed
in refining the message and delivery mechanisms.
Message tone In both country settings, patient participants
shared similar sentiments about the importance of striking
the correct message tone. They wanted encouragement, hope
and practical advice, provided in a tone that is supportive,
kind, polite, and respectful. There was a need for more emo-
tionally supportive messaging that recognised their frustra-
tions and stressors. They explained that they would feel
discouraged by messages with an authoritarian or too direct-
ive a tone (though some felt a directive tone was acceptable
for messages about medication adherence and conveying
warnings about diabetes complications). This contrasted with
staff preferences for more directive messages to emphasise
the importance following professional advice. For example,
staff preferred the use of a directive tone, such as “You must”
as in, “You must remember to pick up your medication”. We
took care to balance this patient-staff tension and opted for a
more motivational tone that patients approved of, and that
was in line with the motivational element of the COM-B be-
haviour changes strategies. For example, we often posed a
question or explanation before offering advice, as in, “Do you
have a clinic appointment this month? Then please do not
miss it. Thnx (DiabetesTeam@Van Clinic)” and, “To keep
your blood sugar levels under control, please keep taking your
meds as prescribed. Thnx (DiabetesTeam@Van Clinic)”.
Message credibility We ensured each message had a sign-
off that clearly identified the sender as part of the health
team at the local clinic, for example “[DiabetesTeam@Van
Clinic]”. We did not use the names of providers. While some
thought using the name of a real doctor is a sign of persona-
lised care, others worried that staff may take offence and re-
gard patients as being too demanding if they asked for the
named doctor. Participants noted that if messages were to be
believable, they should reflect the reality of their (the pa-
tients’) real experience and perceptions of the health service,
and not an idealised view. For example, they did not want
messages to convey an idealised, exaggerated view of the re-
sponsiveness of health staff, but rather and acknowledgement
of issues that frustrated them about the health service.
Local adaptation and translation of messages The
similarities in the patient and staff responses across the sites
meant we could standardise the core content and number
of messages across sites. This still required adjustment of
core messages to fit better with local context, for example,
reflecting local food options, preferences, and lifestyle prac-
tices. Once the content of the 156 brief text-messages in
the StAR2D main library was finalised, we used professional
translators for the isiXhosa and Afrikaans translations in
South Africa and local research staff for the Chichewa
translation in Malawi. Further adaptations were required
Fig. 3 Phase 3: aims, methods and outcomes
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during the translation to consider cultural nuances in local
languages (and given the 160-character limit for SMS mes-
sages). User feedback was critical in guiding this. A health
promotion expert in both sites checked the quality and ap-
propriateness of the final messages.
Delivery mechanisms and tailoring Participants in the
intervention group received brief trial-related messaging and
three to four automated health text-messages per week on
their mobile phone for 12months, free of charge. Participants
in the active control group would receive brief trial-related
and infrequent (one every 6weeks) non-health related mes-
sages. The 12-month delivery period is based on evidence
recommending intervention duration longer than 6months
[12]. The research team used their experience with a prior
study [5, 26, 51], and recommendations from the literature, to
set the frequency and timing of messages to achieve a good
dose response and avoid message fatigue [28, 30]. We tailored
the reminder messages to the service organisation in each site,
such as the frequency of medication pick-ups.
Message delivery was one-directional (did not allow for
a response from participants), a design feature that was
considered important to enhance the feasibility of the
intervention within a resource-constrained setting. Partici-
pants could preselect and change the language of prefer-
ence and select preferred times for the delivery of the
messages via the automated digital platform.
Phase 4: pilot testing the text-message intervention and
delivery mechanisms
We piloted-tested the automated delivery of the brief text
messaging before finalising the StAR2D intervention, as
shown in Fig. 4. (For details of the final StAR2D interven-
tion, see the TIDier checklist in Additional File 2). The
StAR2D main library of messages was loaded onto an auto-
mated text delivery platform using open-source software
(Open Medical Records System (OpenMRS.org)), with
secure information exchange protocols. We used a third-
party bulk SMS-delivery provider. Data was transmitted
using a low-cost mobile phone linked to Sana Mobile
(MIT)), for the data collection system.
The pilot testing allowed for final checks and fine-tuning of
the technical delivery of the automated messaging system be-
fore the intervention was ready to be tested experimentally in
the StAR2D trial. The automated digital delivery mechanism
for this intervention was not integrated to local electronic in-
formation systems, as this was not feasible. In both sites, elec-
tronic information systems were not fully operational.
To pilot test the delivery mechanisms, we signed up
10 participants in each site, and sent them an auto-
mated sample of SMS brief text-messages in their
preferred language on their own mobile phone for a
period of 3 weeks. We did weekly brief telephone in-
terviews (less than 5 min) with pilot-test participants
to check if they received the messages as intended
(the days, time, number of messages per week, in
their chosen language) and could open it in readable
format. We also checked their reaction to the mes-
sage - how they understood and interpreted it. We
did not get any feedback on message content that re-
quired us to make further changes. Technical prob-
lems with the selection of preferred language and
message delivery time were picked up and corrected.
The end of the piloting phase concluded the interven-
tion development research phase, and the intervention
was now ready to be tested experimentally in the StAR2D
trial. The TiDIER checklist in the Additional file 2
provides an overview of the intervention components.
Fig. 4 Phase 4: aim, methods and outcomes
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Discussion
This paper describes and reflects on a systematic and
iterative approach to the development of a brief text-
message intervention that was experimentally tested in a
randomised controlled trial to improve diabetes treat-
ment adherence in sub-Saharan Africa.
We followed the steps recommended by MRC UK
framework for developing and evaluating complex health
interventions [40, 41], and followed guidance for mobile
phone-based brief text-message development elsewhere
[16, 21, 22, 24, 34] aimed at promoting good interven-
tion design prior to experimental testing. This was done
by gathering evidence to inform the design, applying
theory to strengthen the design, getting user-feedback
on acceptability and relevance, and testing feasibility
through piloting, as shown in other study interventions
[24–29, 32, 33, 35, 37, 38, 54].
The step-wise methodology contributes to a growing
body of literature illustrating the value of following a
detailed and systematic approach to intervention devel-
opment [12, 24]. The study builds on our previous
research of developing and testing (through an RCT) a
brief-messaging intervention for adherence to hyperten-
sion treatment in South Africa [26, 51]. By documenting
our formative work, we were able to illustrate the step-
wise approach we took to shaping the intervention and
bring transparency to intervention development process,
thus unpacking the ‘black box’ [25] of our intervention
development.
Our study is the first to systematically document the
development of a brief diabetes-related text-message
library for supporting adherence across two sub-Saharan
sites, using multiple data sources, and a large data set
that is representative of both genders. Similar studies
have been conducted for diabetes in the US [37] and
New Zealand [55], but with more focus on tailoring to
patient preferences and clinical characteristics. The New
Zealand Self-Management Support for Blood Glucose
(SMS4BG) intervention included similar prompts around
diabetes education, management, and lifestyle factors
(healthy eating, exercise, and stress management). It was
also unidirectional (send-only), except for the blood glu-
cose monitoring reminders, which allowed for interaction
around blood glucose test results [55]. The New Zealand
study showed a modest improvement in glycaemic levels
in adults with poorly controlled diabetes [13] that was sus-
tained two years after randomisation [56].
The work of intervention development does not occur
in a vacuum though. There are tensions between the
goals of the developers to design an intervention that
can improve health care within a real world setting,
while considering the limited resources of the health
care context and the research funding context [19, 20].
In this study, we balanced several tensions in crafting
our message content and tone. For example, we priori-
tised medical adherence (taking of medicines as pre-
scribed and medical follow-up), while acknowledging the
importance of healthy lifestyle (secondary) adherence.
We balanced patient and staff perspectives, recognising
the interconnected nature of patient-staff interaction.
We grappled with how best to convey (sometimes com-
plex) health messaging, within a SMS 160-character
limit, and how to do appropriate message translation.
We also had to manage different perspectives among the
research team on how best to strike the balance between
these tensions. Finally, we needed to strike a balance
between design features that could enhance the effect-
iveness, and features that could enhance the feasibility
and potential upscale-ability in low-resource settings.
For instance, in the StAR2D intervention design, we
reduced the technical complexity by limiting the
personalising of patient, clinical, and medication char-
acteristics, to make the intervention more feasible for
implementing in a low-resource setting.
We showed that despite differences in country and
health system contexts, patients in two sub-Saharan
settings had similar experiences of diabetes disease and
of their health care journey. Patient participants identi-
fied a range of personal, social, and health care factors
that pose a risk to their ability to effectively manage
their disease. They also identified the support they got
from family and friends, and from their faith. Similar factors
have been documented elsewhere [1, 4–7, 37, 57, 58]. In
both settings, participants wanted messages to be congru-
ent with their real world experience of health care and ac-
knowledge the social and economic challenges they faced.
As in other studies, participants identified factors that
may influence patient engagement with a mHealth brief
messaging program. These include receiving information
from a credible source, consistent with medical advice,
that provides encouragement and motivation, presented
in a polite and respectful tone [5, 24, 29, 30, 32, 51, 59].
The similarities across settings in sub-Saharan Africa
bodes well for developing standard diabetes messaging
across different contexts [5], but messages still needed
to be adapted for local language and local food and
cultural practices.
In our reporting, we address some, but not all of the
WHO mHealth evidence reporting and assessment
(mERA) guidelines aimed at improving completeness of
mHealth intervention reporting [60]. Chiefly, we de-
scribed the development of the content, delivery and
technical platform, user feedback, content testing,
adaptations to local context. We noted the challenge
of interoperability with routine information systems, a
common barrier for scalability of mHealth interven-
tions [61]. This detailed description of the develop-
ment of our intervention in a low resource setting
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can go some way to support replicability of the inter-
vention development processes elsewhere, including in
other low resource settings.
Limitations
Using theory to design effective digital communication in-
terventions is an ongoing challenge and superficial use of
behaviour change theory is an obstacle to effective inter-
vention design [21, 62]. Our challenge was how to develop
depth in theoretical underpinning of the messages, and
how to measure the ‘active ingredients’ of text-messages
aimed at supporting adherence behaviour [21, 62]. The ex-
tent to which the messages will elicit the intended cogni-
tive, emotional, and behavioural reactions remains
uncertain [12, 18, 63, 64].. Future research may usefully
explore effective ways of infusing behaviour change theory
into targeted patient digital communication, including
how to effectively evaluate the underlying causal mecha-
nisms and identify the ‘active’ ingredients of change asso-
ciated with digital targeted communication using text-
messaging [12, 18, 21, 24, 62–64]. This could include work
to validate a set of brief diabetes-related health messages,
for its applicability across LMIC settings (and for condi-
tions other than diabetes), as was done in the Latin-
American context [27]. Further, studies should explore
the relationship between well-designed, evidence- and
theory-informed interventions, and intervention suc-
cesses, where success includes the extent to which the
intervention can be scaled up to a health system-wide
level [8, 11, 12, 24]. Finally, sampling approaches might
have introduced bias, and the findings might not be
representative of all people with diabetes living in the
study areas in Malawi and South Africa.
Conclusion
The complexity of public health interventions requires
that we pay more attention to intervention development
work. Our documentation and reflection on the StAR2D
intervention development process promotes transpar-
ency, replicability, assessment of intervention quality,
and comparison with other studies.
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